Search Results - "Lessig S"

Reliable change indices for the Italian version of the Montreal Cognitive Assessment (MoCA) in non-demented Parkinson's disease patients.

Authors: Aiello, Edoardo Nicolò Solca, Federica Torre, Silvia et al.

Source: BMC Neurology. 11/4/2024, Vol. 24 Issue 1, p1-5. 5p.

Visual perturbation training to reduce visual dependency in Parkinson's disease: A randomized controlled trial.

Authors: Baggen, Remco J. Van Bladel, Anke Prins, Maarten R. et al.

Source: PLoS ONE. 3/2/2026, Vol. 21 Issue 3, p1-18. 18p.

Lawrence lessig s self defeating crusade.

Authors: Bernstein, Jonathan (AUTHOR)

Source: Bloomberg.com. 8/11/2015, pN.PAG-N.PAG. 1p.

The orexin/hypocretin system in dementia-related neurological disorders: a double-edged sword in cognitive impairment.

Authors: Zhuang, Chenyu Cao, Yuhan Lu, Jiayu et al.

Source: Psychopharmacology. Oct2025, Vol. 242 Issue 10, p2161-2179.

Factors Associated with Performance-Related Pain Among Musicians: A Multicenter Study Using Validated Tools.

Authors: Zão, Ana Altenmüller, Eckart Azevedo, Luís

Source: Journal of Occupational Rehabilitation. Sep2025, Vol. 35 Issue 3, p556-577.

Research progress of chronic fatigue in neurodegenerative diseases.

Authors: Xia, Luxuan Wang, Liye Tian, Wenyang et al.

Source: Neurological Sciences. Oct2025, Vol. 46 Issue 10, p4791-4804. 14p.

Financial capability of people living with Parkinson's disease – A case-control study.

Authors: Ariesen, Akke-Marij D. Tucha, Oliver Bangma, Dorien F. et al.

Source: Applied Neuropsychology: Adult. Mar/Apr2026, Vol. 33 Issue 2, p367-381. 15p.

Subjects: Parkinson's disease, Financial literacy, Case-control method, Cognition disorders, Financial aid, Mild cognitive impairment, Neurodegeneration

Exploring the utility of process scores in elucidating the role of cognitive and affective factors that influence verbal fluency performance in Parkinson's disease.

Authors: Wandell, Catie J. Torres, Karen

Source: Applied Neuropsychology: Adult. Mar/Apr2026, Vol. 33 Issue 2, p382-393. 12p.

Subjects: Parkinson's disease, Executive function, Verbal behavior testing, Apathy, Cognitive ability, Psychological factors

3-Year test-retest reliability in Parkinson's disease and healthy older adults: The Parkinson's progression markers initiative study.

Authors: Ramos, Ari Alex Machado, Liana

Source: Applied Neuropsychology: Adult. Nov/Dec2025, Vol. 32 Issue 6, p1678-1690. 13p.

Subjects: Parkinson's disease, Neuropsychological tests, Cognitive testing, Health of older people, Statistical reliability, Montreal Cognitive Assessment, Intraclass correlation

The Development of a Quantitative Disability Assessment Tool in Patients with Idiopathic Parkinson's Disease.

Authors: Seo, Han Gil Yun, Seo Jung Song, Yoojin et al.

Source: Diagnostics (2075-4418). Sep2024, Vol. 14 Issue 18, p2063. 8p.

Scale consistance in cognitive status awareness of patients with Parkinson's disease.

Authors: Aydemir, Sabiha Tezcan Unutmaz, Elif Yüsra Özkan, Pınar et al.

Source: Turkish Journal of Neurology / Türk Nöroloji Dergisi. Sep2024, Vol. 30 Issue 3, p185-189. 5p.

Does Cognitive Impairment Impact Motor Learning? A Scoping Review of Elderly Individuals With Alzheimer's Disease and Mild Cognitive Impairment.

Authors: Palma, Gisele C. S. Freitas, Tatiana B. Bonuzzi, Giordano Márcio G. et al.

Source: Perceptual & Motor Skills. Oct2023, Vol. 130 Issue 5, p1924-1951.

Validation of the Romanian Version of the Modified Fatigue Impact Scale (MFIS) in Multiple Sclerosis Patients.

Authors: Böckels, Lilia Ignat, Emilian Bogdan Alexa, Daniel et al.

Source: Balneo & PRM Research Journal. Sep2025, Vol. 16 Issue 3, p1-14. 14p.

Association between cerebrospinal fluid Orexin A level and severity of rapid eye movement sleep behaviour disorder in dementia with Lewy bodies.

Authors: Inagawa, Yuta Shimizu, Soichiro Takenoshita, Naoto et al.

Source: Psychogeriatrics. Jan2021, Vol. 21 Issue 1, p128-130. 3p. 1 Graph.

Clinical correlates of serum 25-hydroxyvitamin D in Parkinson's disease.

Authors: Barichella, Michela Cereda, Emanuele Iorio, Laura et al.

Source: Nutritional Neuroscience. Jun2022, Vol. 25 Issue 6, p1128-1136.

Treatment of Apathy in Parkinson's Disease and Implications for Underlying Pathophysiology.

Authors: Maher, Senan Donlon, Eoghan Mullane, Gerard et al.

Source: Journal of Clinical Medicine. Apr2024, Vol. 13 Issue 8, p2216. 14p.

Discordance between Reports of Internalized Symptoms in Persons with Parkinson's Disease and Informants: Results from an Online Survey.

Authors: Kaplan, Rini I. McDowell, Celina Pluim Wall, Juliana et al.

Source: Movement Disorders Clinical Practice. Apr2024, Vol. 11 Issue 4, p391-397. 7p.

Unraveling the interplay between dyskinesia and overactive bladder symptoms in Parkinson's disease: a comprehensive cohort study based on the long-term follow-up database of Parkinson's disease.

Authors: Jin, Hong Du, Yiheng Yan, Jiahui et al.

Source: BMC Neurology. 3/11/2024, Vol. 24 Issue 1, p1-9. 9p.

Delineation of Apathy Subgroups in Parkinson's Disease: Differences in Clinical Presentation, Functional Ability, Health‐related Quality of Life, and Caregiver Burden.

Authors: Eglit, Graham M.L. Lopez, Francesca Schiehser, Dawn M. et al.

Source: Movement Disorders Clinical Practice. Jan2021, Vol. 8 Issue 1, p92-99. 8p.

Repurposing approved drugs as ferroptosis modulators: a critical review of clinical trials in cancer and neurodegeneration.

Authors: Zayed M Massoud A Elwakeel E et al.

Source: Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2026 Jun 19. Date of Electronic Publication: 2026 Jun 19.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0326264 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1912 (Electronic) Linking ISSN: 00281298 NLM ISO Abbreviation: Naunyn Schmiedebergs Arch Pharmacol Subsets: MEDLINE